- Home
- VSTA vs RCKT Comparison
VSTA vs RCKT Comparison
Compare VSTA & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSTA
- RCKT
- Stock Information
- Founded
- VSTA 1966
- RCKT 1999
- Country
- VSTA Brazil
- RCKT United States
- Employees
- VSTA N/A
- RCKT N/A
- Industry
- VSTA Other Consumer Services
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- VSTA Real Estate
- RCKT Health Care
- Exchange
- VSTA Nasdaq
- RCKT Nasdaq
- Market Cap
- VSTA 332.9M
- RCKT 328.6M
- IPO Year
- VSTA 2020
- RCKT N/A
- Fundamental
- Price
- VSTA $4.28
- RCKT $3.28
- Analyst Decision
- VSTA Sell
- RCKT Buy
- Analyst Count
- VSTA 1
- RCKT 13
- Target Price
- VSTA N/A
- RCKT $12.96
- AVG Volume (30 Days)
- VSTA 14.1K
- RCKT 6.0M
- Earning Date
- VSTA 08-06-2025
- RCKT 08-07-2025
- Dividend Yield
- VSTA N/A
- RCKT N/A
- EPS Growth
- VSTA N/A
- RCKT N/A
- EPS
- VSTA 1.09
- RCKT N/A
- Revenue
- VSTA $313,466,268.00
- RCKT N/A
- Revenue This Year
- VSTA $12.29
- RCKT N/A
- Revenue Next Year
- VSTA $11.91
- RCKT $108.43
- P/E Ratio
- VSTA $3.94
- RCKT N/A
- Revenue Growth
- VSTA 8.99
- RCKT N/A
- 52 Week Low
- VSTA $1.60
- RCKT $2.19
- 52 Week High
- VSTA $5.49
- RCKT $22.01
- Technical
- Relative Strength Index (RSI)
- VSTA 56.69
- RCKT 51.17
- Support Level
- VSTA $3.78
- RCKT $2.88
- Resistance Level
- VSTA $4.38
- RCKT $3.74
- Average True Range (ATR)
- VSTA 0.18
- RCKT 0.27
- MACD
- VSTA 0.00
- RCKT 0.02
- Stochastic Oscillator
- VSTA 83.33
- RCKT 35.43
About VSTA Vasta Platform Limited
Vasta Platform Ltd operates as an education company in Brazil, engaged in providing end-to-end educational and digital solutions that cater to all needs of private schools operating in the K-12 educational segment. Its business segments are Content and EdTech Platform, and Digital Platform. The Content and EdTech platform derives its results from educational content solutions through digital and printed content, including textbooks, learning systems and other complementary educational services. The Digital Platform enables private schools to aggregate multiple learning strategies and helps them to focus on education through the Business' physical and digital e-commerce platform and other digital services.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.